<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01462201</url>
  </required_header>
  <id_info>
    <org_study_id>US-0711</org_study_id>
    <nct_id>NCT01462201</nct_id>
  </id_info>
  <brief_title>A Multicenter,2-Arm,Randomized,Controlled Study Evaluate the Effectiveness of the UltraShape® Contour I VER 3.1 System for Non-Invasive Reduction in Abdominal Circumference</brief_title>
  <official_title>A Multicenter,Two-Arm,Randomized,Controlled Study for the Evaluation of the Treatment of Adipose Tissue Using a Focused Ultrasound Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UltraShape</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Syneron Medical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>UltraShape</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the effectiveness of the Contour I VER 3.1
      System on abdominal midsection circumference reduction relative to no treatment.

      The secondary objective of this study is to assess subject satisfaction measured with a
      self-assessment questionnaire
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective of this study is to evaluate the effectiveness of the Contour I VER 3.1 System on abdominal midsection circumference reduction relative to no treatment</measure>
    <time_frame>5-6 months</time_frame>
    <description>Reduction in circumference measurement of the abdomen from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess subject satisfaction measured with a self-assessment questionnaire</measure>
    <time_frame>5-6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">156</enrollment>
  <condition>Body Sculpting</condition>
  <arm_group>
    <arm_group_label>Group 1 - Non Invasive Ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 1 3 visits - Measurement of abdominal circumferences 3 visits - Treatment with Ultrashape Contour I VER 3.1 4 visits - Follow up visits The intervention is non invasive ultrasound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 - Non Invasive Ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 2 3 visits - Treatment with Contour I VER 3.1 system 3 visits - Measurements of abdominal circumference 4 visits - Follow Up visits The intervention is non invasive ultrasound.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non Invasive Ultrasound</intervention_name>
    <description>Each treatment session is estimated to take approximately 60 minutes and will be performed on a bi-weekly basis.</description>
    <arm_group_label>Group 1 - Non Invasive Ultrasound</arm_group_label>
    <arm_group_label>Group 2 - Non Invasive Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female or male subjects, 18 and 65 years of age at the time of enrollment

          2. Abdominal fat thickness of at least 1.5 cm (measurement by caliper)

          3. For women of child-bearing potential:

               1. negative urine pregnancy test.

               2. Women of child bearing age are required to be using an acceptable form of birth
                  control for the duration of the study.

          4. General good health confirmed by medical history and skin examination of the treated
             area

          5. Written informed consent to participate in the study

          6. Ability to comply with the requirements of the study

          7. BMI ≤ 30

             Intra-procedural Inclusion criteria (prior to starting the treatment phase):

             subjects are eligible to continue the study and participate in the treatment phase if
             she meets all of the following intra-procedural inclusion criteria:

          8. For women of child-bearing potential: negative pregnancy test

          9. Abdominal fat thickness of at least 1.5 cm prior to initial treatment (measurement by
             caliper)

        Exclusion Criteria:

          1. History of hypertension, ischemic heart disease, valvular heart disease, congestive
             heart failure, pacemaker/defibrillator, abdominal aortic aneurysm

          2. Current hyperlipidemia, diabetes mellitus, hepatitis, liver disease, HIV positive
             status, blood coagulopathy or excessive bleeding, autoimmune or connective tissue
             disease or malignancy.

          3. Previous liposuction in the treatment area

          4. History of skin disease in the treatment area, known tendency to form keloids or poor
             wound healing

          5. Skin lesions in the treatment area other than simple nevi on physical examination
             (e.g., atypical nevus, tattoo, abrasions) including depressed scars in the treatment
             area

          6. Poor skin quality (i.e., laxity)

          7. Abdominal wall diastasis or hernia on physical examination

          8. Abnormal kidney, liver or coagulation functions, abnormal lipid profile or blood count
             within the last 3 months

          9. Obesity (BMI &gt; 30)

         10. Childbirth within the last 12 months or breastfeeding women.

         11. Any acute or chronic condition which, in the opinion of the Investigator, could
             interfere with the conduct of the study

         12. Unstable weight within the last 6 months (i.e., ± 3% weight change in the prior six
             months)

         13. Inability to comply with circumference measurement procedure (e.g., inability to held
             breath for the required duration)

         14. Participation in another clinical study within the last six months.

         15. Previous body contouring treatments in the areas of the abdomen and flanks.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dr. William Patrick Coleman, III</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MD Laser Skin &amp; Vein Institute</name>
      <address>
        <city>Hunt Valley</city>
        <state>Maryland</state>
        <zip>21030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New-Jersey Plastic Surgery</name>
      <address>
        <city>Montclair</city>
        <state>New Jersey</state>
        <zip>07042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Jeffrey Kenkel</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Plastic Surgery and Burns Rabin Medical Center - Beilinson Hospital</name>
      <address>
        <city>Petah Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2011</study_first_submitted>
  <study_first_submitted_qc>October 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2011</study_first_posted>
  <last_update_submitted>November 10, 2013</last_update_submitted>
  <last_update_submitted_qc>November 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>focused ultrasound</keyword>
  <keyword>mechanical fat destruction</keyword>
  <keyword>Body Sculpting</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

